The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies
Bonnie Huang(Center for Cancer Research), Claudia Palena(National Institutes of Health)
Cited by 81
Related Papers
The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance
|Vaccines|2016|393
Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer
|JCI Insight|2017|164
Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity
|Journal for ImmunoTherapy of Cancer|2020|96